The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Valcyte 50 mg/ml powder for oral solution

Roche Products (Ireland) Ltd PA2307/009/002

Main Information

Trade NameValcyte 50 mg/ml powder for oral solution
Active SubstancesValganciclovir hydrochloride
Dosage FormPowder for oral solution
Licence HolderRoche Products (Ireland) Ltd
Licence NumberPA2307/009/002

Group Information

ATC CodeJ05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors
J05AB14 valganciclovir


Licence Issued15/08/2008
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back